medigraphic.com

2018, Number 2

<< Back Next >>

Rev Educ Bioquimica 2018; 37 (2)

Prevención prenatal de la diabetes y obesidad

Tixi VWI, Fernández MMC

Language: Spanish
References: 52
Page: 48-55
PDF size: 350.64 Kb.


ABSTRACT

Type-2 diabetes is an important public health problem whose prevalence is increasing. Nowadays it is known that environmental factors such as lifestyle, hypercaloric diets and physical inactivity are risk factors for type-2 diabetes development. In addition to these factors, it has been widely documented that maternal nutrition during gestation and lactation influence on the development of type-2 diabetes. Epidemiological, clinical and experimental studies have come into the concept known as “Metabolic Programming”, which state that environmental conditions during critical stages of development contribute to the development of diseases such as diabetes or obesity later in life. Since the “metabolic programming” occurs at a period in which the mothers is focused in the well-being of the children provides particular advantage on diet interventions to decrease one of the risk factors for the development of type-2 diabetes and obesity in the adult life.


REFERENCES

  1. DeFronzo R A, Ferrannini E, Zimmet P, & Alberti G (Eds.) (2015) International textbook of diabetes mellitus, Chichester, UK: John Wiley & Sons, Ltd. p1228

  2. International Diabetes Federation (2017) IDF Diabetes Atlas 8th Edition. 8th. [online] https://www.idf.org/our-activities/advocacyawareness/ resources-and-tools/134:idfdiabetes- atlas-8th-edition.html

  3. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, y Koplan JP (2001) The continuing epidemics of obesity and diabetes in the United States. JAMA. 286: 1195–200

  4. WHO | Obesity y overweight (2018) WHO. [online] http://www.who.int/mediacentre/ factsheets/fs311/en/

  5. Ximena Raimann T (2011) Obesidad y sus complicaciones. Rev. Médica Clínica Las Condes. 22: 20–26

  6. Rinaudo P, y Wang E (2012) Fetal programming and metabolic syndrome. Annu. Rev. Physiol. 74: 107–30

  7. Barker DJ (1995) Fetal origins of coronary heart disease. BMJ. 311: 171–4

  8. Barker DJ (1998) In utero programming of chronic disease. Clin. Sci. (Lond). 95: 115–28

  9. Morley R y Dwyer T. (2001) Fetal origins of adult disease? Clin. Exp. Pharmacol. Physiol. 28: 962–6

  10. Yang Z y Huffman SL (2013) Nutrition in pregnancy and early childhood and associations with obesity in developing countries. Matern. Child Nutr. 9: 105–119

  11. Gluckman PD y Hanson MA (2004) The developmental origins of the metabolic syndrome. Trends Endocrinol. Metab. 15: 183–7

  12. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, y Robinson JS (1993) Fetal nutrition and cardiovascular disease in adult life. Lancet (London, England). 341: 938–41

  13. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C y Winter PD (1991) Fetal and infant growth and impaired glucose tolerance at age 64. BMJ. 303: 1019–22

  14. Roseboom TJ, Painter RC, van Abeelen AF M, Veenendaal MVE y de Rooij SR (2011) Hungry in the womb: what are the consequences? Lessons from the Dutch famine. Maturitas. 70: 141–5

  15. Ravelli AC, van Der Meulen JH, Osmond C, Barker DJ y Bleker OP (1999) Obesity at the age of 50 y in men and women exposed to famine prenatally. Am. J. Clin. Nutr. 70: 811–6

  16. Stanner SA y Yudkin JS (2001) Fetal programming and the Leningrad Siege study. Twin Res. 4: 287–92

  17. Yudkin JS y Stanner S (1998) Prenatal exposure to famine and health in later life. Lancet. 351: 1361–1362

  18. Branca F, Piwoz E, Schultink W y Sullivan LM (2015) Nutrition and health in women, children, and adolescent girls. BMJ. 351: h4173

  19. Fernandez-Twinn DS y Ozanne SE (2006) Mechanisms by which poor early growth programs type-2 diabetes, obesity and the metabolic syndrome. Physiol. Behav. 88: 234–243

  20. Boloker J, Gertz SJ y Simmons RA (2002) Gestational diabetes leads to the development of diabetes in adulthood in the rat. Diabetes. 51: 1499–506

  21. Vuguin PM (2007) Animal Models for Small for Gestational Age and Fetal Programing of Adult Disease. Horm. Res. Paediatr. 68: 113–123

  22. Dahri, S., Snoeck, A., Reusens-Billen, B., Remacle, C., and Hoet, J. J. (1991) Islet function in offspring of mothers on low-protein diet during gestation. Diabetes. 40 Suppl 2: 115–20

  23. Snoeck A, Remacle C, Reusens B y Hoet J J (1990) Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol. Neonate. 57: 107–18

  24. Garofano A, Czernichow P y Bréant B (1997) In utero undernutrition impairs rat beta-cell development. Diabetologia. 40: 1231–4

  25. Kwon EJ y Kim YJ (2017) What is fetal programming?: a lifetime health is under the control of in utero health. Obstet. Gynecol. Sci. 60: 506–519

  26. Rathmann W y Giani G (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 27: 2568–9; author reply 2569

  27. Zimmet PZ, McCarty DJ y de Courten MP. The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J. Diabetes Complications. 11: 60–8

  28. Baier LJ y Hanson RL (2004) Genetic studies of the etiology of type 2 diabetes in Pima Indians: hunting for pieces to a complicated puzzle. Diabetes. 53: 1181–6

  29. Narro J, Secretario R, Salud D, Antonio P, Morales K, De Prevención S, De Y P, Salud L, Guillermina M, González V, De Administración S, Finanzas Y, Mondragón M, Kalb Y, Ancer Rodríguez J, Ruiz-Palacios GM, Santos Y, Sánchez JS, Tépoz Y, O ’ GJ, Cuevas S, Hugo M, De R, Guerrero C, Del P, De C, Comisión L y De Bioética N (2016) Encuesta Nacional de Salud y Nutrición de Medio Camino 2016 (ENSANUT MC2016). [online] http://fmdiabetes.org/wp-content/ uploads/2017/04/ENSANUT2016-mc.pdf

  30. Barquera S, Tovar-Guzmán V, Campos-Nonato I, González-Villalpando C y Rivera-Dommarco J (2003) Geography of diabetes mellitus mortality in Mexico: an epidemiologic transition analysis. Arch. Med. Res. 34: 407–414

  31. Mohd-Shukri N, Duncan A, Denison F, Forbes S, Walker B, Norman J y Reynolds R (2015) Health Behaviours during Pregnancy in Women with Very Severe Obesity. Nutrients. 7: 8431–8443

  32. Gunatilake RP y Perlow JH (2011) Obesity and pregnancy: clinical management of the obese gravida. Am. J. Obstet. Gynecol. 204: 106–119

  33. Phelan S, Hart C, Phipps M, Abrams B, Schaffner A, Adams A y Wing, R. (2011) Maternal Behaviors during Pregnancy Impact Offspring Obesity Risk. Exp. Diabetes Res. 2011: 1–9

  34. Buckley AJ, Keserü B, Briody J, Thompson M, Ozanne SE y Thompson CH (2005) Altered body composition and metabolism in the male offspring of high fat-fed rats. Metabolism. 54: 500–7

  35. Cerf ME, Muller CJ, Du Toit DF, Louw J y Wolfe- Coote SA (2006) Hyperglycaemia and reduced glucokinase expression in weanling offspring from dams maintained on a high-fat diet. Br. J. Nutr. 95: 391–6

  36. Cerf ME, Williams K, Chapman CS y Louw J (2007) Compromised beta-cell development and beta-cell dysfunction in weanling offspring from dams maintained on a high-fat diet during gestation. Pancreas. 34: 347–53

  37. Cerf ME (2015) High fat programming of beta cell compensation, exhaustion, death and dysfunction. Pediatr. Diabetes. 16: 71–8

  38. Buchanan TA, Xiang AH y Page KA (2012) Gestational diabetes mellitus: risks and management during and after pregnancy. Nat. Rev. Endocrinol. 8: 639–649

  39. Guariguata L, Linnenkamp U, Beagley J, Whiting DR y Cho NH (2014) Global estimates of the prevalence of hyperglycaemia in pregnancy. Diabetes Res. Clin. Pract. 103: 176–185

  40. Pettitt DJ, Knowler WC, Bennett PH, Aleck KA y Baird HR. Obesity in offspring of diabetic Pima Indian women despite normal birth weight. Diabetes Care. 10: 76–80

  41. Gillman MW, Rifas-Shiman S, Berkey CS, Field AE y Colditz GA (2003) Maternal gestational diabetes, birth weight, and adolescent obesity. Pediatrics. 111: e221-6

  42. Farrar D, Fairley L, Santorelli G, Tuffnell D, Sheldon TA, Wright J, van Overveld L y Lawlor DA (2015) Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort. lancet. Diabetes Endocrinol. 3: 795–804

  43. Yaghootkar H y Freathy RM (2012) Genetic origins of low birth weight. Curr. Opin. Clin. Nutr. Metab. Care. 15: 258–264

  44. Bianco-Miotto T, Craig JM, Gasser YP, van Dijk SJ y Ozanne SE (2017) Epigenetics and DOHaD: from basics to birth and beyond. J. Dev. Orig. Health Dis. 8: 513–519

  45. Jang HS, Shin WJ, Lee JE y Do JT (2017) CpG and Non-CpG Methylation in Epigenetic Gene Regulation and Brain Function. Genes (Basel). 8: 148

  46. Simmons RA (2007) Developmental origins of diabetes: the role of epigenetic mechanisms. Curr. Opin. Endocrinol. Diabetes Obes. 14: 13–16

  47. Park JH, Stoffers DA, Nicholls RD y Simmons RA (2008) Development of type 2 diabetes following intrauterine growth retardation in rats is associated with progressive epigenetic silencing of Pdx1. J. Clin. Invest. 118: 2316–24

  48. Sandovici I, Smith NH, Nitert MD, Ackers- Johnson M, Uribe-Lewis S, Ito Y, Jones RH, Marquez VE, Cairns W, Tadayyon M, O’Neill LP, Murrell A, Ling C, Constância M y Ozanne SE (2011) Maternal diet and aging alter the epigenetic control of a promoter-enhancer interaction at the Hnf4a gene in rat pancreatic islets. Proc. Natl. Acad. Sci. U. S. A. 108: 5449–54

  49. Alfaradhi MZ, Kusinski LC, Fernandez-Twinn DS, Pantaleão LC, Carr SK, Ferland-Mccollough D, Yeo GS H, Bushell M y Ozanne SE. Maternal Obesity in Pregnancy Developmentally Programs Adipose Tissue Inflammation in Young, Lean Male Mice Offspring. 10.1210/ en.2016-1314

  50. Cora’ D, Re A, Caselle M y Bussolino F (2017) MicroRNA-mediated regulatory circuits: outlook and perspectives. Phys. Biol. 14: 45001

  51. Lie S, Morrison JL, Williams-Wyss O, Suter C M, Humphreys DT, Ozanne SE, Zhang S, MacLaughlin SM, Kleemann DO, Walker S K, Roberts CT y McMillen IC (2014) Periconceptional Undernutrition Programs Changes in Insulin-Signaling Molecules and MicroRNAs in Skeletal Muscle in Singleton and Twin Fetal Sheep1. Biol. Reprod. 90: 5

  52. Chango A y Pogribny IP (2015) Considering maternal dietary modulators for epigenetic regulation and programming of the fetal epigenome. Nutrients. 7: 2748–70




2020     |     www.medigraphic.com